In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity

被引:117
作者
El Fahime, E
Torrente, Y
Caron, NJ
Bresolin, MD
Tremblay, JP
机构
[1] CHU Laval, Unite Rech Genet Humaine, Quebec City, PQ G1V 4G2, Canada
[2] Univ Milan, Ctr Dino Ferrari, Inst Clin Neurol, Milan, Italy
关键词
myoblast migration; MMP2; MT1-MMP; myoblast transplantation; ECM;
D O I
10.1006/excr.2000.4962
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Muscle cell migration and extracellular matrix remodeling are essential aspects of muscle development and regeneration, In this study, using a new technique to assess in vivo myoblast migration, we have confirmed previous results showing that the C2C12 myoblast cell line exhibits a higher migratory capacity than primary myoblasts, To test the hypothesis that matrix metalloproteinases (MMPs) are required for the migration of C2C12 myoblasts, we determined whether a synthetic metalloproteinase inhibitor, BB94 (Batimastat), inhibited this process in vivo. Pretreatment with BB94 for 3 days decreased the C2C12 migration at 2 days after cell injection. Since MMP expression is thus necessary for myoblast migration, we have undertaken the identification and characterization of the MMPs expressed by the C2C12 cell line, An RT-PCR assay was used to determine the pattern of MMP mRNA expression by the C2C12 cell line. The proteolytic activities of the MMPs secreted in the culture medium were also assessed by gelatin zymography. The results showed that MMP2 (gelatinase A, 72-kDa type IV collagenase) and MT1-MMP transcripts were expressed by this cell line; however, only MMP2 was secreted and was able to be activated in the extracellular environment. This cell line failed to express MMP9 (gelatinase B, 92-kDa type IV collagenase), stromelysine 2, or stromelysine 3. Our observation that the membrane type MMP (MT1-MMP) transcript is also expressed by the C2C12 suggests that the MMP2 preform (pro-MMP2), may be activated by the MT1-MMP. This possibility is supported by our observation that the pretreatment of C2C12 with concanavalin A (which is known to induce the expression of MT1-MMP) resulted in the processing of pro-MMP2 to its mature form, in a dose-dependent manner, Overexpression and activation of MMP2 in normal myoblasts showed significant increased migration of mouse myoblasts in vivo. Our finding that MMP2 and MT1-MMP gene are coexpressed by C2C12 myoblasts could account for the high migratory capacity of C2C12. Together these results supported the importance of MMP2 and its activation by MT1-MMP for myoblast migration. (C) 2000 Academic Press.
引用
收藏
页码:279 / 287
页数:9
相关论文
共 41 条
[1]   SYSTEMIC DELIVERY OF RECOMBINANT PROTEINS BY GENETICALLY MODIFIED MYOBLASTS [J].
BARR, E ;
LEIDEN, JM .
SCIENCE, 1991, 254 (5037) :1507-1509
[2]   THE RECEPTOR FOR UROKINASE-PLASMINOGEN ACTIVATOR [J].
BLASI, F ;
STOPPELLI, MP ;
CUBELLIS, MV .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, 32 (03) :179-186
[3]   Increased myogenic potential and fusion of matrilysin-expressing myoblasts transplanted in mice [J].
Caron, NJ ;
Asselin, I ;
Morel, G ;
Tremblay, JP .
CELL TRANSPLANTATION, 1999, 8 (05) :465-476
[4]  
DAVIES B, 1993, CANCER RES, V53, P3652
[5]  
DAVIES B, 1993, CANCER RES, V53, P2087
[6]   Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles [J].
Floyd, SS ;
Clemens, PR ;
Ontell, MR ;
Kochanek, S ;
Day, CS ;
Yang, J ;
Hauschka, SD ;
Balkir, L ;
Morgan, J ;
Moreland, MS ;
Feero, GW ;
Epperly, M ;
Huard, J .
GENE THERAPY, 1998, 5 (01) :19-30
[7]  
Guerette B, 1997, J IMMUNOL, V159, P2522
[8]   Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation [J].
Guerette, B ;
Asselin, I ;
Skuk, D ;
Entman, M ;
Tremblay, JP .
CELL TRANSPLANTATION, 1997, 6 (02) :101-107
[9]   Efficient myoblast transplantation in mice immunosuppressed with monoclonal antibodies and CTLA4 Ig [J].
Guerette, B ;
Wood, K ;
Roy, R ;
Tremblay, JP .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (04) :1932-1934
[10]  
GUERETTE B, 1995, TRANSPLANTATION, V60, P1011